Semaglutide in India: Indications, Side Effects, and Pricing

Introduction

Semaglutide, a breakthrough medication in the field of diabetes management, has garnered significant attention in India due to its promising results and potential benefits for patients with type 2 diabetes. This article aims to provide an overview of semaglutide, including its indications, possible side effects, and pricing in the Indian market.

Indications

Semaglutide belongs to the class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It is indicated as an add-on to exercise and diet to enhance glycemic control in adults suffering from type 2 diabetes mellitus. The medication improves blood sugar control by increasing insulin release, decreasing glucagon secretion, and delaying gastric emptying.

Side Effects

Semaglutide offers significant benefits for diabetes management, but it's essential to be aware of potential side effects. These can include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Constipation
  • Weight loss

These side effects are minor to moderate and tend to subside as the body gets used to the medicine. If these side effects start to affect a patient, they are urged to see their doctor.

In some rare cases and conditions, more severe side effects can occur. These include:

  • Pancreatitis
  • Kidney problems
  • Allergic reactions

Patients should seek immediate medical supervision if they experience severe abdominal pain, persistent nausea or vomiting, severe or prolonged diarrhea, or signs of an allergic reaction like rash, itching, or swelling.

Pricing from India

Considering the pricing of pharmaceuticals is essential for patients and healthcare providers. Semaglutide was available in India under various brand names, and its pricing could vary based on factors such as dosage strength and packaging. Newer medications like semaglutide may initially be priced higher due to research and development costs.

For accurate and up-to-date pricing information for semaglutide from India, it is recommended to consult local pharmacies or healthcare professionals. Patients are also encouraged to inquire about potential discounts, insurance coverage, or patient assistance programs that may help alleviate the financial burden associated with the medication.

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found to b
Read more

What is Non-Small Cell Lung Cancer? What are the stages of NSCLC?

Image
NSCLC, the most common form of lung cancer. It occurs when the healthy cells in the lung change and start growing in an abnormal way, forming a specific mass addressed as tumor, lesion, or nodule. A tumor may develop anywhere in the lung and could be cancerous or benign. A cancerous tumor mainly is malignant, means, it has potential in order to spread to the rest part of the body. A benign tumor is the tumor that can grow but can not spread.  Non-Small Cell Lung Cancer (NSCLC) occurs in the epithelial cells. Doctors can also describe this form of Cancer (NSCLC) based on the type of the epithelial cell where the cancer usually starts.  Adenocarcinoma starts in cells that produce mucus.  Squamous carcinoma basically developed in the cells that line the airways.  Large cell carcinoma usually begins in the cells other than the two types which are described above.  It’s necessary for healthcare providers to distinguish between lung cancer that begins in the squamous cells from lung cancer
Read more

Trodelvy: All about the drug

Image
Indication and Usage The medicine Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate drug, which is used in the treatment of adults suffering from locally advanced or metastatic triple-negative breast (mTNBC) cancer, HR+/HER2- metastatic breast cancer, and locally advanced or metastatic urothelial cancer (mUC). It is used when it is not possible to remove cancer with surgery. Trodelvy  comes in the form of single-dose vials in 180 mg for intravenous infusion. Dosage Its dosage is based on body weight, and the recommended dosage is 10 mg/kg administered intravenously once weekly on the first day and eighth day of a repeating 21-day cycle. Administration First infusion: The drug is infused in the body for 3 hours, and during the infusion, the patient is observed for any adverse reaction caused by the infusion. After 30 minutes of infusion, observation should be done again to check for any post-infusion reaction. Subsequent Infusion: If the drug is tolerated in t
Read more